Melanoma Journal Articles for October 2016
The Journal of Biological Chemistry
Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKC? Signaling Axis*
- Brian A. Shapiro‡,1,
- Ngoc T. Vu1,
- Michael D. Shultz‡,
- Jacqueline C. Shultz,
- Jennifer A. Mietla,
- Mazen M. Gouda,
- Adly Yacoub¶,
- Paul Dent,?,**,
- Paul B. Fisher?,**,‡‡2,
- Margaret A. Park,**3and
- Charles E. Chalfant
First Published onAugust 12, 2016doi: 10.1074/jbc.M116.737569October 7, 2016The Journal of Biological Chemistry291, 21669-21681.
Nature
Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. https://dx.doi.org/10.1016/j.cmet.2016.08.011 (2016)
Oncotarget
The prognostic significance of heparanase expression in metastatic melanoma
Olga Vornicova1,*, Ilanit Boyango2*, Sari Feld2, Inna Naroditsky3, Olga Kazarin1, Yaniv Zohar3, Yariv Tiram2, Neta Ilan2, Ofer Ben-Izhak3, Israel Vlodavsky2, Gil Bar-Sela
DOI: 10.18632/oncotarget.12492
Received: September 20, 2016 Accepted: September 26, 2016 Published: October 06, 2016
New England Journal of Medicine
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
Alexander M.M. Eggermont, M.D., Ph.D., Vanna Chiarion-Sileni, M.D., Jean-Jacques Grob, M.D., Ph.D., Reinhard Dummer, M.D., Jedd D. Wolchok, M.D., Ph.D., Henrik Schmidt, M.D., Omid Hamid, M.D., Caroline Robert, M.D., Ph.D., Paolo A. Ascierto, M.D., Jon M. Richards, M.D., Céleste Lebbé, M.D., Ph.D., Virginia Ferraresi, M.D., Michael Smylie, M.D., Jeffrey S. Weber, M.D., Ph.D., Michele Maio, M.D., Ph.D., Lars Bastholt, M.D., Laurent Mortier, M.D., Ph.D., Luc Thomas, M.D., Ph.D., Saad Tahir, M.D., Axel Hauschild, M.D., Ph.D., Jessica C. Hassel, M.D., F. Stephen Hodi, M.D., Corina Taitt, M.D., Veerle de Pril, M.Sc., Gaetan de Schaetzen, Ph.D., Stefan Suciu, Ph.D., and Alessandro Testori, M.D.
October 8, 2016DOI: 10.1056/NEJMoa1611299
“Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species"
Irina V Lebedeva, Zao-Zhong Su, Devanand Sarkar, Shinichi Kitada, Paul Dent, Samuel Waxman, John C Reed, Paul B Fisher, Cancer Res., 63 (2003)
Journal of Biological Chemistry
Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth*
Alexander J. Lakhter‡, James Hamilton§, Raymond L. Konger¶, Nickolay Brustovetsky§, Hal E. Broxmeyer‡ and Samisubbu R. Naidu
First Published onAugust 18, 2016doi: 10.1074/jbc.M115.712166October 14, 2016The
Journal of Biological Chemistry291, 21869-21879.
Journal for ImmunoTherapy of Cancer
Acute visual loss after ipilimumab treatment for metastatic melanoma
Melissa A. Wilson, Kelly Guld, Steven Galetta, Ryan D. Walsh, Julia Kharlip, Madhura Tamhankar, Suzanne McGettigan, Lynn M. Schuchter and Leslie A. Fecher
Journal for ImmunoTherapy of Cancer20164:66
DOI: 10.1186/s40425-016-0170-9
© The Author(s). 2016
Received: 24 March 2016 Accepted: 29 September 2016
Published: 18 October 2016
Eggermont AMM et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med 2016 Oct 8; [e-pub]. (http://dx.doi.org/10.1056/NEJMoa1611299)
ORIGINAL RESEARCH
Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973–2012)
Authors Mahendraraj K, Lau CSM, Lee I, Chamberlain RS
Received 26 May 2016
Accepted for publication 28 June 2016
Published 25 October 2016 Volume 2016:10 Pages 2113—2119
DOI https://dx.doi.org/10.2147/OPTH.S113623
Int. J. Mol. Sci. 2016, 17(11), 1124; doi:10.3390/ijms17111124
Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/?-Catenin Pathway
Jia Huo, Yanfei Zhang, Ruilian Li, Yuan Wang, Jiawen Wu and Dingwei Zhang
Received: 14 April 2016 / Revised: 20 May 2016 / Accepted: 31 May 2016 / Published: 27 October 2016
Cancer Cell
UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis
Laurence Wurth, Panagiotis Papasaikas, David Olmeda, Nadine Bley, Guadalupe T. Calvo, Santiago Guerrero, Daniela Cerezo-Wallis,Javier Martinez-Useros, María García-Fernández, Stefan üttelmaier, Maria S. Soengas, Fátima Gebauer
Publication stage: In Press Corrected Proof
DOI: http://dx.doi.org/10.1016/j.ccell.2016.10.004
Malignant Melanoma Arising at the Site of a Previously Excised Giant Congenital Melanocytic Nevus
Carrie C. Coughlin, MD1; M. Laurin Council, MD1; Alejandro A. Gru, MD2; et alRyan C. Fields, MD3;Susan J. Bayliss, MD1
JAMA Dermatol. 2014;150(1):100-101. doi:10.1001/jamadermatol.2013.5775
Systemic Therapy for Previously Untreated Advanced BRAF-Mutated MelanomaA Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
Tahira Devji, BSc1; Oren Levine, MD1,2; Binod Neupane, PhD1; et alJoseph Beyene, PhD1;Feng Xie, PhD1,3
JAMA Oncol. Published online October 27, 2016. doi:10.1001/jamaoncol.2016.4877
Journal of Clinical Oncology
Sunscreen Use in the Prevention of Melanoma: Common Sense Rules
DOI: 10.1200/JCO.2016.69.5874 Journal of Clinical Oncology – published online before print October 31, 2016